GWAS |
- Alzheimer's disease (late onset) ( 30820047)
- Alzheimer's disease or fasting glucose levels (pleiotropy) ( 30805717)
- Autism spectrum disorder or schizophrenia ( 28540026)
- Immunoglobulin A ( 20694011)
- Pulse pressure ( 30578418)
- Schizophrenia ( 29483656)
- Serum metabolite levels ( 33031748)
|
- Bipolar disorder and schizophrenia ( 21057379)
- Breast cancer in childhood cancer survivors ( 29059430)
- Breast cancer in childhood cancer survivors treated with more than 10 gray radiotherapy ( 29059430)
- Calcium levels ( 25972035)
- Carotid plaque burden ( 28282560)
- Chronic rhinosinusitis ( 33393196)
- Cognitive ability, years of educational attainment or schizophrenia (pleiotropy) ( 31374203)
- Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes ( 29221444)
- Diastolic blood pressure ( 27841878)
- Femur bone mineral density x serum urate levels interaction ( 34046847)
- Gut microbiota relative abundance (unclassified genus belonging to family Ruminococcaceae) ( 33208821)
- Hearing loss in noise exposure ( 33242228)
- Inflammatory skin disease ( 25574825)
- Intelligence (MTAG) ( 29326435)
- Myopia (pathological) ( 23049088)
- Non-lobar intracerebral hemorrhage (MTAG) ( 31430377)
- Obesity-related traits ( 23251661)
- Plasma anti-thyroid peroxidase levels ( 29678681)
- Refractive error ( 32231278)
- Response to amphetamines ( 22952603)
- Retinal detachment or retinal break ( 31816047)
- Serum metabolite concentrations in chronic kidney disease ( 29545352)
- Severe COVID-19 infection with respiratory failure (analysis I) ( 32558485)
- Triacylglyceride levels ( 31551469)
|